rs3732765

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001393769.1(MED12L):​c.3734G>A​(p.Arg1245Gln) variant causes a missense change. The variant allele was found at a frequency of 0.339 in 1,613,148 control chromosomes in the GnomAD database, including 98,006 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 7195 hom., cov: 33)
Exomes 𝑓: 0.35 ( 90811 hom. )

Consequence

MED12L
NM_001393769.1 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 3.96

Publications

47 publications found
Variant links:
Genes affected
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
P2RY12 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 8
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025772154).
BP6
Variant 3-151372636-G-A is Benign according to our data. Variant chr3-151372636-G-A is described in ClinVar as Benign. ClinVar VariationId is 1321166.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.372 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12LNM_001393769.1 linkc.3734G>A p.Arg1245Gln missense_variant Exon 27 of 45 ENST00000687756.1 NP_001380698.1
P2RY12NM_022788.5 linkc.-180+12056C>T intron_variant Intron 1 of 2 ENST00000302632.4 NP_073625.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12LENST00000687756.1 linkc.3734G>A p.Arg1245Gln missense_variant Exon 27 of 45 NM_001393769.1 ENSP00000508695.1
P2RY12ENST00000302632.4 linkc.-180+12056C>T intron_variant Intron 1 of 2 1 NM_022788.5 ENSP00000307259.4

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42246
AN:
151992
Hom.:
7200
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0872
Gnomad AMI
AF:
0.553
Gnomad AMR
AF:
0.296
Gnomad ASJ
AF:
0.323
Gnomad EAS
AF:
0.133
Gnomad SAS
AF:
0.263
Gnomad FIN
AF:
0.399
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.376
Gnomad OTH
AF:
0.313
GnomAD2 exomes
AF:
0.309
AC:
77623
AN:
251044
AF XY:
0.316
show subpopulations
Gnomad AFR exome
AF:
0.0752
Gnomad AMR exome
AF:
0.280
Gnomad ASJ exome
AF:
0.314
Gnomad EAS exome
AF:
0.141
Gnomad FIN exome
AF:
0.404
Gnomad NFE exome
AF:
0.372
Gnomad OTH exome
AF:
0.330
GnomAD4 exome
AF:
0.345
AC:
504606
AN:
1461038
Hom.:
90811
Cov.:
35
AF XY:
0.345
AC XY:
250927
AN XY:
726858
show subpopulations
African (AFR)
AF:
0.0689
AC:
2306
AN:
33466
American (AMR)
AF:
0.284
AC:
12721
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.315
AC:
8239
AN:
26120
East Asian (EAS)
AF:
0.140
AC:
5555
AN:
39660
South Asian (SAS)
AF:
0.266
AC:
22927
AN:
86224
European-Finnish (FIN)
AF:
0.398
AC:
21259
AN:
53398
Middle Eastern (MID)
AF:
0.327
AC:
1882
AN:
5762
European-Non Finnish (NFE)
AF:
0.369
AC:
410233
AN:
1111330
Other (OTH)
AF:
0.323
AC:
19484
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
16371
32742
49112
65483
81854
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12640
25280
37920
50560
63200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.278
AC:
42243
AN:
152110
Hom.:
7195
Cov.:
33
AF XY:
0.278
AC XY:
20664
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.0869
AC:
3611
AN:
41544
American (AMR)
AF:
0.296
AC:
4525
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
1118
AN:
3466
East Asian (EAS)
AF:
0.133
AC:
691
AN:
5186
South Asian (SAS)
AF:
0.263
AC:
1266
AN:
4820
European-Finnish (FIN)
AF:
0.399
AC:
4210
AN:
10546
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.376
AC:
25574
AN:
67956
Other (OTH)
AF:
0.313
AC:
660
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1454
2909
4363
5818
7272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.337
Hom.:
31512
Bravo
AF:
0.262
TwinsUK
AF:
0.369
AC:
1368
ALSPAC
AF:
0.353
AC:
1362
ESP6500AA
AF:
0.0819
AC:
361
ESP6500EA
AF:
0.376
AC:
3235
ExAC
AF:
0.306
AC:
37134
Asia WGS
AF:
0.171
AC:
595
AN:
3478
EpiCase
AF:
0.376
EpiControl
AF:
0.370

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nizon-Isidor syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.010
T;.
Eigen
Benign
0.062
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.0026
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.69
N;.
PhyloP100
4.0
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.25
N;N
REVEL
Benign
0.12
Sift
Benign
0.58
T;T
Sift4G
Benign
0.30
T;T
Polyphen
0.30
B;P
Vest4
0.18
MPC
0.46
ClinPred
0.025
T
GERP RS
5.0
Varity_R
0.076
gMVP
0.27
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3732765; hg19: chr3-151090424; COSMIC: COSV56372833; API